NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

VARIATION ON ANCILLARY COMPONENT

1. Is it a requirement to submit application for endorsement letter when a change occurs to a particular ancillary component?

Yes. This is in line with the requirements stated in Section 6.2 : Changes/Variation To Particulars Of A Registered Medical Device-Drug Combination Product, Guideline for Registration of Drug-Medical Device and Medical Device-Drug Combination Products.

2. Variation procedure for a registered combination product.
3. What is the validity period of the endorsement letter issued for variation of a particular ancillary component ?

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

  • Last Modified: Friday 01 November 2024, 09:13:24.

Search

Main Menu English